Assignee
DONG A ST CO LTD
KR·22 granted patents·18 pending applications·14 citations·filing 2013–2023
Top patents by PatentIndex Score
40 records- 0182US9676796B2Tricyclic benzoxaborole compound, preparation method and use thereofDONG A ST CO LTD·Filed 2014·Granted Jun 13, 2017·8 cites·16 claims
- 0279US10398747B2Composition comprising the extract of herbal combination for preventing or treating diabetic peripheral neuropathyDONG A ST CO LTD·Filed 2018·Granted Sep 3, 2019·2 cites·12 claims
- 0374US10428055B2Substituted piperidines having GPR119 agonistic activityDONG A ST CO LTD·Filed 2015·Granted Oct 1, 2019·2 cites·17 claims
- 0471US2021121449A1Novel oxazolidinone derivativesDONG A ST CO LTD·Filed 2020·Application pending·0 cites
- 0570US12115159B2Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease, containing GPR119 ligand as active ingredientDONG A ST CO LTD·Filed 2019·Granted Oct 15, 2024·1 cites·5 claims
- 0669US2020078345A1Novel oxazolidinone derivativesDONG A ST CO LTD·Filed 2019·Application pending·0 cites
- 0767US9828339B2Biphenyl derivatives and methods for preparing sameDONG A ST CO LTD·Filed 2014·Granted Nov 28, 2017·1 cites·13 claims
- 0866US2021113648A1Composition comprising the extract of herbal combination for preventing or treating diabetic peripheral neuropathyDONG A ST CO LTD·Filed 2020·Application pending·0 cites
- 0966US2018344716A1Novel oxazolidinone derivativesDONG A ST CO LTD·Filed 2018·Application pending·0 cites
- 1065US10813973B2Composition comprising the extract of herbal combination for preventing or treating diabetic peripheral neuropathyDONG A ST CO LTD·Filed 2017·Granted Oct 27, 2020·0 cites·16 claims
- 1164US2014350059A1Novel oxazolidinone derivativesDONG A ST CO LTD·Filed 2014·Application pending·0 cites
- 1263US10709752B2Composition comprising the extract of herbs for preventing or treating neurodegenerative disordersDONG A ST CO LTD·Filed 2017·Granted Jul 14, 2020·0 cites·14 claims
- 1363US9163043B2Oxazolidinone derivativesDONG A ST CO LTD·Filed 2013·Granted Oct 20, 2015·0 cites·20 claims
- 1462US2017333414A1Novel oxazolidinone derivativesDONG A ST CO LTD·Filed 2017·Application pending·0 cites
- 1561US2020397845A1Composition comprising the extract of herbs for preventing or treating neurodegenerative disordersDONG A ST CO LTD·Filed 2020·Application pending·0 cites
- 1660US11713344B2Acylated oxyntomodulin peptide analogDONG A ST CO LTD·Filed 2021·Granted Aug 1, 2023·0 cites·14 claims
- 1760US2017049763A1Novel oxazolidinone derivativesDONG A ST CO LTD·Filed 2016·Application pending·0 cites
- 1859US12168073B2Percutaneous absorption preparation comprising stabilized donepezilDONG A ST CO LTD·Filed 2019·Granted Dec 17, 2024·0 cites·5 claims
- 1958US2025000814A1Percutaneous absorption preparation for treating dementia comprising memantine enanthateDONG A ST CO LTD·Filed 2022·Application pending·0 cites
- 2057US11236142B2Acylated oxyntomodulin peptide analogDONG A ST CO LTD·Filed 2018·Granted Feb 1, 2022·0 cites·9 claims
- 2157US2025282735A1Bicycle compounds as tead inhibitorDONG A ST CO LTD·Filed 2023·Application pending·0 cites
- 2253US12527749B2Percutaneous absorption preparation comprising donepezil with improved stabilityDONG A ST CO LTD·Filed 2021·Granted Jan 20, 2026·0 cites·15 claims
- 2353US10159667B2Composition containing a DPP-IV inhibitor for preventing or treating renal diseasesDONG A ST CO LTD·Filed 2014·Granted Dec 25, 2018·0 cites·3 claims
- 2451US10894768B2Salt of (R)-(1-methylpyrrolidine-3-yl)methyl(3′-chloro-4′-fluoro-[1,1′-biphenyl]-2-yl)carbamate and crystal form thereofDONG A ST CO LTD·Filed 2016·Granted Jan 19, 2021·0 cites·32 claims
- 2551US2023117286A1Pharmaceutical composition for prevention or treatment of nonalcoholic steatohepatitisDONG A ST CO LTD·Filed 2021·Application pending·0 cites
- 2651US2023143119A1Pharmaceutical composition for prevention or treatment of diabetes and metabolic diseases associated therewithDONG A ST CO LTD·Filed 2021·Application pending·0 cites
- 2750US2023220035A1Long-acting glp-1 and glucagon receptor dual agonistDONG A ST CO LTD·Filed 2021·Application pending·0 cites
- 2849US12240836B2Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereofDONG A ST CO LTD·Filed 2022·Granted Mar 4, 2025·0 cites·7 claims
- 2948US11992562B2Percutaneous absorption preparation for treating dementia comprising donepezilDONG A ST CO LTD·Filed 2018·Granted May 28, 2024·0 cites·7 claims
- 3047US2023150970A1Aminopyrimidine derivatives and their use as aryl hydrocarbon receptor modulatorsDONG A ST CO LTD·Filed 2021·Application pending·0 cites
- 3145US2023147257A1Pyridopyrimidinone derivatives and their use as aryl hydrocarbon receptor modulatorsDONG A ST CO LTD·Filed 2021·Application pending·0 cites
- 3243US2018065768A1Gas substitution deviceDONG A ST CO LTD·Filed 2016·Application pending·0 cites
- 3342US9375483B2Stable liquid pharmaceutical composition containing piroxicam or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt and the manufacturing method thereofDONG A ST CO LTD·Filed 2013·Granted Jun 28, 2016·0 cites·14 claims
- 3440US9771348B2Method for preparing benzamide derivative, novel intermediate used in preparation of benzamide, and method for preparing novel intermediateDONG A ST CO LTD·Filed 2014·Granted Sep 26, 2017·0 cites·22 claims
- 3540US2016106774A1Liquid pharmaceutical composition containing piroxicam and hyaluronic acid for the treatment of osteoarthritisDONG A ST CO LTD·Filed 2014·Application pending·0 cites
- 3639US9533977B2Oxazolidinone derivative as CETP inhibitor, its preparation method, and pharmaceutical composition comprising the sameDONG A ST CO LTD·Filed 2014·Granted Jan 3, 2017·0 cites·23 claims
- 3738US10160724B2Tetrahydropyridine derivatives and their use as antibacterial agentsDONG A ST CO LTD·Filed 2017·Granted Dec 25, 2018·0 cites·8 claims
- 3837US2017340638A1Stable pharmaceutical composition comprising pemetrexed or pharmaceutically acceptable salt thereofDONG A ST CO LTD·Filed 2015·Application pending·0 cites
- 3936US11840574B2Anti-DR5 antibody and use thereofDONG A ST CO LTD·Filed 2018·Granted Dec 12, 2023·0 cites·21 claims
- 4029US9809583B2Oxazolidine-based compound and selective androgen receptor agonist comprising sameDONG A ST CO LTD·Filed 2015·Granted Nov 7, 2017·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when DONG A ST CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →